NOTCH1 MUTATIONS IDENTIFY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS THAT DO NOT BENEFIT OF AN INDUCTION AND CONSOLIDATION TREATMENT BASED ON RITUXIMAB

被引：0

作者：

Del Poeta, G. ^{[1
]}

Dal Bo, M. ^{[2
]}

Ragusa, D. ^{[1
]}

Del Principe, M. ^{[1
]}

Pozzo, F. ^{[2
]}

Rossi, D. ^{[3
]}

Buccisano, F. ^{[1
]}

Maurillo, L. ^{[1
]}

Niscola, P. ^{[1
]}

de Fabritiis, P. ^{[1
]}

Perrotti, A. ^{[1
]}

Venditti, A. ^{[1
]}

Amadori, S. ^{[1
]}

Gaidano, G. ^{[3
]}

Gattei, V. ^{[2
]}

机构：

[1] Univ Tor Vergata, Hematol, Rome, Italy

[2] IRCCS, CRO, Clin & Expt Oncohematol Unit, Aviano, PN, Italy

[3] Amedeo Avogadro Univ Eastern Piedmont, Div Hematol Clin & Expt Med, Novara, Italy

来源：

HAEMATOLOGICA | 2013年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P102

引用

页码：43 / 44

页数：2

共 50 条

[1] NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment
Michele Dal Bo
Maria Ilaria Del Principe
Federico Pozzo
Dario Ragusa
Pietro Bulian
Davide Rossi
Giovanni Capelli
Francesca Maria Rossi
Pasquale Niscola
Francesco Buccisano
Riccardo Bomben
Antonella Zucchetto
Luca Maurillo
Paolo de Fabritiis
Sergio Amadori
Gianluca Gaidano
Valter Gattei
Giovanni Del Poeta
Annals of Hematology, 2014, 93 : 1765 - 1774
[2] NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment
Dal Bo, Michele
Del Principe, Maria Ilaria
Pozzo, Federico
Ragusa, Dario
Bulian, Pietro
Rossi, Davide
Capelli, Giovanni
Rossi, Francesca Maria
Niscola, Pasquale
Buccisano, Francesco
Bomben, Riccardo
Zucchetto, Antonella
Maurillo, Luca
de Fabritiis, Paolo
Amadori, Sergio
Gaidano, Gianluca
Gattei, Valter
Del Poeta, Giovanni
ANNALS OF HEMATOLOGY, 2014, 93 (10) : 1765 - 1774
[3] NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients
Willander, Kerstin
Dutta, Ravi Kumar
Ungerback, Jonas
Gunnarsson, Rebeqa
Juliusson, Gunnar
Fredrikson, Mats
Linderholm, Mats
Soderkvist, Peter
BMC CANCER, 2013, 13
[4] NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients
Kerstin Willander
Ravi Kumar Dutta
Jonas Ungerbäck
Rebeqa Gunnarsson
Gunnar Juliusson
Mats Fredrikson
Mats Linderholm
Peter Söderkvist
BMC Cancer, 13
[5] Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia
Arruga, F.
Gizdic, B.
Serra, S.
Vaisitti, T.
Ciardullo, C.
Coscia, M.
Laurenti, L.
D'Arena, G.
Jaksic, O.
Inghirami, G.
Rossi, D.
Gaidano, G.
Deaglio, S.
LEUKEMIA, 2014, 28 (05) : 1060 - 1070
[6] Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia
F Arruga
B Gizdic
S Serra
T Vaisitti
C Ciardullo
M Coscia
L Laurenti
G D'Arena
O Jaksic
G Inghirami
D Rossi
G Gaidano
S Deaglio
Leukemia, 2014, 28 : 1060 - 1070
[7] NOTCH1 mutations in chronic lymphocytic leukemia with trisomy 12
Orlandi, Ester M.
Rossi, Marianna
GENES CHROMOSOMES & CANCER, 2012, 51 (11): : 1063 - 1063
[8] Outcomes in Chronic Lymphocytic Leukemia Patients With NOTCH1 Signaling Pathway Mutations
O'Brien, Susan M.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (07) : 23 - 24
[9] Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond
Pozzo, Federico
Bittolo, Tamara
Tissino, Erika
Zucchetto, Antonella
Bomben, Riccardo
Polcik, Laura
Dannewitz Prosseda, Svenja
Hartmann, Tanja Nicole
Gattei, Valter
CANCERS, 2022, 14 (12)
[10] NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome
N Villamor
L Conde
A Martínez-Trillos
M Cazorla
A Navarro
S Beà
C López
D Colomer
M Pinyol
M Aymerich
M Rozman
P Abrisqueta
T Baumann
J Delgado
E Giné
M González-Díaz
J M Hernández
E Colado
A R Payer
C Rayon
B Navarro
M José Terol
F Bosch
V Quesada
X S Puente
C López-Otín
P Jares
A Pereira
E Campo
A López-Guillermo
Leukemia, 2013, 27 : 1100 - 1106

← 1 2 3 4 5 →